The U.S. Food and Drug Administration (FDA) recently issued a warning letter to Alkermes, Inc. due to misbranding on the drug Vivitrol, which is used to prevent opioid…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.